Generated by GPT-5-mini| Janet Hannah Clark | |
|---|---|
| Name | Janet Hannah Clark |
| Birth date | 1972 |
| Birth place | Boston, Massachusetts |
| Occupation | Researcher, Professor |
| Discipline | Molecular Biology |
| Institutions | Massachusetts Institute of Technology; Harvard Medical School; Broad Institute |
| Alma mater | Stanford University; University of Cambridge |
Janet Hannah Clark is an American molecular biologist and translational researcher known for work on signal transduction, chromatin regulation, and translational oncology. Her career spans laboratory research, academic leadership, and collaborative consortia across major centers in the United States and the United Kingdom. Clark's contributions link basic studies in cell signaling with clinical applications in targeted therapies, and she has held positions at leading research institutions and consortia.
Clark was born in Boston and raised in Cambridge, where early exposure to the Massachusetts Institute of Technology campus and programs at the Harvard Museum of Natural History influenced her interest in biology. She completed an undergraduate degree at Stanford University, majoring in Biochemistry and obtaining research experience in laboratories connected to the Beckman Center for Molecular and Genetic Medicine. Clark pursued doctoral studies at the University of Cambridge, affiliating with Trinity College, Cambridge and conducting PhD research in molecular genetics under mentorship that connected to the Medical Research Council units. During her postgraduate work she collaborated with investigators associated with the Wellcome Trust and presented at meetings hosted by the European Molecular Biology Laboratory.
After her PhD, Clark returned to the United States for a postdoctoral fellowship at the Harvard Medical School and the Broad Institute, where she trained in functional genomics and high-throughput screening. She joined the faculty of the Massachusetts Institute of Technology Department of Biology as an assistant professor, later obtaining tenure and serving as director of a translational program linked to the Dana-Farber Cancer Institute. Clark has been a principal investigator in multi-institutional projects with partners at the National Institutes of Health, collaborators at the Salk Institute for Biological Studies, and international coordinators from the European Research Council-funded networks. In leadership roles she has overseen core facilities modeled on the Genomics Core Facility and coordinated cross-disciplinary projects involving investigators from the Broad Institute, Cold Spring Harbor Laboratory, and Johns Hopkins University.
Clark has also served on advisory boards and review panels for agencies such as the National Cancer Institute, the Wellcome Trust, and the Howard Hughes Medical Institute. She has held visiting appointments at the University of Oxford and participated in scientific symposia at institutions including the Max Planck Society and the Fred Hutchinson Cancer Center.
Clark's laboratory focused on signal transduction pathways mediated by receptor tyrosine kinases and downstream chromatin modulators, integrating techniques from structural biology, genomics, and chemical biology. Her work examined interactions among proteins in the PI3K/AKT pathway, links to the RAS/MAPK pathway, and regulatory effects on histone-modifying complexes such as those related to the Polycomb Group and SWI/SNF complex. Using CRISPR-based functional screens with collaborators at the Broad Institute and chemical probes developed in partnership with teams at the Scripps Research Institute, Clark identified synthetic lethal interactions that informed targeted therapeutics evaluated in early-phase trials coordinated with the Food and Drug Administration regulatory framework.
Her group contributed to large-scale datasets deposited in consortia aligned with the International Cancer Genome Consortium and the Cancer Genome Atlas. Clark authored influential papers that connected oncogenic signaling with epigenetic state transitions, citing mechanistic links to transcription factors like MYC, TP53, and NF-κB and cooperating chromatin regulators such as EZH2 and BRG1. She co-led cross-disciplinary efforts that translated bench discoveries into biomarker-driven strategies tested with clinical partners at the Dana-Farber Cancer Institute and the Memorial Sloan Kettering Cancer Center.
Methodological contributions from Clark's laboratory included optimized chromatin immunoprecipitation protocols adopted by practitioners at the European Molecular Biology Laboratory and computational pipelines for integrative analysis used by groups at the Institute for Systems Biology and the Broad Institute. Her team deposited reagent collections into repositories associated with the Addgene plasmid library and trained numerous postdoctoral fellows who went on to faculty positions at institutions such as University of California, San Francisco and Yale University.
Clark resides in the Boston area and maintains ties with academic communities in both the United States and the United Kingdom. She is active in mentoring programs affiliated with the American Association for Cancer Research and serves on outreach initiatives with the Society for Neuroscience and the Biophysical Society to promote laboratory training and science communication. Outside the laboratory, Clark has participated in public engagement events at the Museum of Science (Boston) and contributes to science policy discussions hosted by the Belfer Center for Science and International Affairs.
Clark's scientific achievements have been recognized with awards and fellowships including a career development award from the National Institutes of Health, a research fellowship from the Wellcome Trust during her doctoral training, and election to leadership roles in the American Society for Cell Biology. She received institutional honors such as the Massachusetts Institute of Technology Early Career Faculty Award and collaborative grants supported by the Howard Hughes Medical Institute and foundations associated with the Susan G. Komen Foundation. Clark has been an invited keynote speaker at meetings organized by Cold Spring Harbor Laboratory, the European Molecular Biology Organization, and the American Association for the Advancement of Science.
Category:1972 births Category:American molecular biologists Category:Living people